192(top 1%)
papers
32.8K(top 1%)
citations
78(top 1%)
h-index
182(top 0.1%)
g-index
197
all documents
34.9K
doc citations
3.3K
citing journals

Top Articles

#TitleJournalYearCitations
1Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy20164,701
2Guidelines for the use and interpretation of assays for monitoring autophagyAutophagy20123,122
3Ferroptosis: process and functionCell Death and Differentiation20162,270
4The Beclin 1 network regulates autophagy and apoptosisCell Death and Differentiation20111,972
5Autophagy promotes ferroptosis by degradation of ferritinAutophagy20161,318
6Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology20161,263
7PAMPs and DAMPs: signal 0s that spur autophagy and immunityImmunological Reviews2012899
8Endocytosis, intracellular sorting, and processing of exosomes by dendritic cellsBlood2004868
9Endogenous HMGB1 regulates autophagyJournal of Cell Biology2010819
10Interleukin-17 promotes angiogenesis and tumor growthBlood2003743
11The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunityImmunological Reviews2007565
12RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and InflammationJournal of Translational Medicine2009491
13Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosisHepatology2016462
14HSPB1 as a novel regulator of ferroptotic cancer cell deathOncogene2015459
15Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic ShockJournal of Experimental Medicine1998457
16High-mobility group box 1 and cancerBiochimica Et Biophysica Acta - Gene Regulatory Mechanisms2010442
17HMGB1 release and redox regulates autophagy and apoptosis in cancer cellsOncogene2010421
18High-Mobility Group Box 1, Oxidative Stress, and DiseaseAntioxidants and Redox Signaling2011420
19Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell HypothesisJournal of Clinical Pharmacology2005411
20HMGB1 in Cancer: Good, Bad, or Both?Clinical Cancer Research2013399
21The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agentsMolecular and Cellular Oncology2015301
22Cancer and Inflammation: Promise for Biologic TherapyJournal of Immunotherapy2010293
23The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survivalCell Death and Differentiation2010281
24High-Mobility Group Box 1 Is Essential for Mitochondrial Quality ControlCell Metabolism2011266
25Posttranslational modification of autophagy-related proteins in macroautophagyAutophagy2015264
26IL-18–induced CD83+CCR7+ NK helper cellsJournal of Experimental Medicine2005260
27Oncolytic viruses as therapeutic cancer vaccinesMolecular Cancer2013252
28p53/HMGB1 Complexes Regulate Autophagy and ApoptosisCancer Research2012220
29HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cellsLeukemia2011218
30Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor ImmunityFrontiers in Oncology2014216
31Oxidative stress-mediated HMGB1 biologyFrontiers in Physiology2015210
32The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergeticsOncogene2014192
33Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9Journal of Hepatology2015189
34HMGB1: A novel Beclin 1-binding protein active in autophagyAutophagy2010183
35High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cellsProceedings of the National Academy of Sciences of the United States of America2002170
36Complementary Dendritic Cell–activating Function of CD8+ and CD4+ T CellsJournal of Experimental Medicine2002167
37Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12Cancer Research1999160
38Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situBlood2001159
39Differential Antitumor Effects of Administration of Recombinant IL-18 or Recombinant IL-12 Are Mediated Primarily by Fas-Fas Ligand- and Perforin-Induced Tumor Apoptosis, RespectivelyJournal of Immunology1999149
40Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cellsCancer Immunology, Immunotherapy2009148
41T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor TherapyMolecular Therapy2014140
42The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasiaProceedings of the National Academy of Sciences of the United States of America2012139
43Eat-Me: Autophagy, Phagocytosis, and Reactive Oxygen Species SignalingAntioxidants and Redox Signaling2013138
44Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyJournal of Immunology1999134
45Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor RegressionCancer Research2012133
46A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cellsJournal of Immunological Methods2002128
47EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma VaccinesNeoplasia2005126
48Cell-Mediated Autophagy Promotes Cancer Cell SurvivalCancer Research2012122
49Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alphaJournal of Immunology1998120
50Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or “self” antigens induce antitumor immunityin vivoEuropean Journal of Immunology1997119